Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Survey: UK Young People Generally Bullish on Cryptocurrency, Not Just Limited to Right-Wing Voters

Survey: UK Young People Generally Bullish on Cryptocurrency, Not Just Limited to Right-Wing Voters

BlockBeatsBlockBeats2026/03/25 11:41

BlockBeats News, March 25th, a survey commissioned by the an exchange Institute showed that cryptocurrency is popular among the younger generation in the UK, and supporters are not limited to right-wing political parties.


The data shows that among left-leaning party supporters aged 16 to 25 in the UK, 64% have heard of cryptocurrency, 74% are familiar with Bitcoin, higher than some right-wing voters; 42% believe that cryptocurrency will have a positive impact on their future finances.


Despite Nigel Farage's UK Reform Party's outspoken support for the crypto industry, the survey indicates that the appeal of cryptocurrency has crossed party lines. At the same time, the UK government is facing industry pressure to advance crypto regulation. The current policymaking involving institutions such as the Bank of England is still considered slow-moving by some in the industry.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12